Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Inhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy.

Owens TW, Gilmore AP, Streuli CH, Foster FM.

J Carcinog Mutagen. 2013 May 27;Suppl 14. pii: S14-004.

2.

Specific β-containing integrins exert differential control on proliferation and two-dimensional collective cell migration in mammary epithelial cells.

Jeanes AI, Wang P, Moreno-Layseca P, Paul N, Cheung J, Tsang R, Akhtar N, Foster FM, Brennan K, Streuli CH.

J Biol Chem. 2012 Jul 13;287(29):24103-12. doi: 10.1074/jbc.M112.360834. Epub 2012 Apr 16.

3.

Analysis of inhibitor of apoptosis protein family expression during mammary gland development.

Owens TW, Foster FM, Tanianis-Hughes J, Cheung JY, Brackenbury L, Streuli CH.

BMC Dev Biol. 2010 Jun 28;10:71. doi: 10.1186/1471-213X-10-71.

4.

Role for X-linked Inhibitor of apoptosis protein upstream of mitochondrial permeabilization.

Owens TW, Foster FM, Valentijn A, Gilmore AP, Streuli CH.

J Biol Chem. 2010 Jan 8;285(2):1081-8. doi: 10.1074/jbc.M109.072322. Epub 2009 Oct 29.

5.

How adhesion signals reach a mitochondrial conclusion--ECM regulation of apoptosis.

Gilmore AP, Owens TW, Foster FM, Lindsay J.

Curr Opin Cell Biol. 2009 Oct;21(5):654-61. doi: 10.1016/j.ceb.2009.05.009. Epub 2009 Jun 29. Review.

PMID:
19570669
6.

Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer.

Foster FM, Owens TW, Tanianis-Hughes J, Clarke RB, Brennan K, Bundred NJ, Streuli CH.

Breast Cancer Res. 2009;11(3):R41. doi: 10.1186/bcr2328. Epub 2009 Jun 29.

7.

Are class II phosphoinositide 3-kinases potential targets for anticancer therapies?

Traer CJ, Foster FM, Abraham SM, Fry MJ.

Bull Cancer. 2006 May;93(5):E53-8.

8.

Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration.

Maffucci T, Cooke FT, Foster FM, Traer CJ, Fry MJ, Falasca M.

J Cell Biol. 2005 Jun 6;169(5):789-99. Epub 2005 May 31.

9.

The phosphoinositide (PI) 3-kinase family.

Foster FM, Traer CJ, Abraham SM, Fry MJ.

J Cell Sci. 2003 Aug 1;116(Pt 15):3037-40. Review. No abstract available.

10.

Genistein inhibits lysosomal enzyme release by suppressing Ca2+ influx in HL-60 granulocytes.

Foster FM, Conigrave AD.

Cell Calcium. 1999 Jan;25(1):69-76.

PMID:
10191961
11.

Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells.

Jiang L, Foster FM, Ward P, Tasevski V, Luttrell BM, Conigrave AD.

Biochem Biophys Res Commun. 1997 Jul 9;236(1):626-30.

PMID:
9223456
12.

The Richmond Minority Ministry in Dentistry 1850-1950.

Foster FM.

Va Dent J. 1997 Jul-Sep;74(3):12-5. No abstract available.

PMID:
9540747
13.

Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells.

Jiang L, Foster FM, Ward P, Tasevski V, Luttrell BM, Conigrave AD.

Biochem Biophys Res Commun. 1997 Mar 27;232(3):626-30. Corrected and republished in: Biochem Biophys Res Commun. 1997 Jul 9;236(1):626-30.

PMID:
9126325
14.
15.

Statewide treatment outcome assessment in Colorado: the Colorado Client Assessment Record (CCAR).

Ellis RH, Wilson NZ, Foster FM.

Community Ment Health J. 1984 Spring;20(1):72-89.

PMID:
6723260
16.

Alcoholism and ethnicity: a comparative study of alcohol use patterns across ethnic groups.

Wanberg K, Lewis R, Foster FM.

Int J Addict. 1978 Nov;13(8):1245-62.

PMID:
744659
17.

A differential assessment model for alcoholism. The scales of the Alcohol Use Inventory.

Wanberg KW, Horn JL, Foster FM.

J Stud Alcohol. 1977 Mar;38(3):512-43.

PMID:
859335
18.

Dimensions of treatment outcome. A factor-analytic study of alcoholics' responses to a follow-up questionnaire.

Foster FM, Horn JL, Wanberg KW.

Q J Stud Alcohol. 1972 Dec;33(4):1079-98. No abstract available.

PMID:
4648627
19.

Effective personnel communications in radiology department management.

Foster FM.

Radiol Technol. 1972 Jan;43(4):209-13. No abstract available.

PMID:
4670959
20.

EEG studies in sensory induced seizures.

FOSTER FM, MADOW L.

Dis Nerv Syst. 1948 May;9(5):158. No abstract available.

PMID:
18932408
21.

Degenerative changes in cerebral arteries following administration of desoxycorticosterone acetate.

FOSTER FM, CANTAROW A, et al.

J Clin Endocrinol Metab. 1946 Jan;6:77-87. No abstract available.

PMID:
21014409
22.

Action of acetylcholine on motor cortex; correlation of effects of acetylcholine and epilepsy.

FOSTER FM.

Arch Neurol Psychiatry. 1945 Nov-Dec;54:391-4. No abstract available.

PMID:
21012277

Supplemental Content

Loading ...
Support Center